Obviously we are the unpopular opinion here.
Had heaps of shares in MSB previously and held during the aGVHD and COVID saga. Each time each clinical trial failed to reach the primary endpoint, it would get spun into a different reason/scapegoat. Not to mention their cash burn is rather insane and will require a cap raise in the near distant future.
Since sold out of a lot of my holding at a huge loss. Still holding some in case but honestly not really hopeful.
A case for why FDA needs MSB to succeed, page-23
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.015(1.52%) |
Mkt cap ! $1.158B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $1.008M | 1.005M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 27359 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 125894 | 17 |
View Market Depth
| Last trade - 11.16am 15/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |